Profund Advisors’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,422
Closed -$288K 1156
2023
Q4
$288K Sell
10,422
-396
-4% -$24.1K 0.01% 800
2023
Q3
$658K Sell
10,818
-3,916
-27% -$275K 0.04% 389
2023
Q2
$970K Sell
14,734
-117
-0.8% -$8.56K 0.05% 318
2023
Q1
$945K Buy
+14,851
New +$1.7M 0.06% 315
2021
Q3
Sell
-1,042
Closed -$432K 1362
2021
Q2
$432K Buy
1,042
+129
+14% +$51.1K 0.01% 778
2021
Q1
$357K Sell
913
-131
-13% -$64.5K 0.01% 826
2020
Q4
$585K Buy
1,044
+94
+10% +$59.6K 0.03% 476
2020
Q3
$664K Sell
950
-158
-14% -$123K 0.03% 374
2020
Q2
$876K Buy
1,108
+305
+38% +$230K 0.05% 289
2020
Q1
$478K Sell
803
-292
-27% -$285K 0.04% 375
2019
Q4
$1.25M Buy
1,095
+113
+12% +$123K 0.05% 294
2019
Q3
$1.17M Sell
982
-66
-6% -$101K 0.06% 294
2019
Q2
$1.73M Sell
1,048
-134
-11% -$232K 0.08% 237
2019
Q1
$2.41M Buy
1,182
+21
+2% +$37K 0.12% 164
2018
Q4
$1.49M Sell
1,161
-268
-19% -$411K 0.09% 207
2018
Q3
$2.7M Buy
1,429
+226
+19% +$467K 0.1% 174
2018
Q2
$2.44M Sell
1,203
-175
-13% -$399K 0.1% 167
2018
Q1
$3.05M Sell
1,378
-110
-7% -$280K 0.12% 133
2017
Q4
$3.43M Sell
1,488
-55
-4% -$112K 0.13% 134
2017
Q3
$2.75M Buy
1,543
+255
+20% +$356K 0.11% 153
2017
Q2
$1.75M Sell
1,288
-106
-8% -$128K 0.08% 225
2017
Q1
$1.64M Sell
1,394
-116
-8% -$118K 0.07% 249
2016
Q4
$1.21M Sell
1,510
-70
-4% -$55.6K 0.06% 332
2016
Q3
$1.39M Sell
1,580
-38
-2% -$27.5K 0.07% 273
2016
Q2
$907K Buy
1,618
+4
+0.2% +$2.27K 0.04% 434
2016
Q1
$889K Sell
1,614
-375
-19% -$230K 0.05% 398
2015
Q4
$1.66M Buy
1,989
+5
+0.3% +$5K 0.08% 197
2015
Q3
$2.2M Buy
+1,984
New +$3.62M 0.13% 116

Other funds holding BLUE

Profund Advisors's BLUE Position: Q1 2024 in Review

Profund Advisors sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 10,422 shares — an estimated $288K sold.

Profund Advisors first reported a position in BLUE in Q3 2015 and held it in 28 quarters. The position peaked at $3.43M in Q4 2017. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.

  • Profund Advisors reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
  • Profund Advisors sold 10,422 bluebird bio shares in Q1 2024, an estimated $288K.
  • Profund Advisors first reported a position in bluebird bio in Q3 2015 and held it in 28 quarters.
  • Profund Advisors's bluebird bio position peaked at $3.43M in Q4 2017.
  • 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.

Based on Profund Advisors's 13F filing for Q1 2024, filed 8 May 2024.